The Manufacturers Life Insurance Company Has $196.70 Million Stock Position in Procter & Gamble Company (The) $PG

The Manufacturers Life Insurance Company reduced its position in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 31.6% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,341,390 shares of the company’s stock after selling 618,970 shares during the period. The Manufacturers Life Insurance Company’s holdings in Procter & Gamble were worth $196,704,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in PG. BlackRock Inc. acquired a new stake in Procter & Gamble during the 2nd quarter valued at $27,862,105,000. State Street Corp raised its position in Procter & Gamble by 1.0% in the 4th quarter. State Street Corp now owns 101,618,926 shares of the company’s stock valued at $14,563,008,000 after purchasing an additional 984,102 shares during the last quarter. Geode Capital Management LLC boosted its stake in Procter & Gamble by 3.3% in the fourth quarter. Geode Capital Management LLC now owns 62,647,882 shares of the company’s stock worth $8,962,689,000 after purchasing an additional 1,974,556 shares in the last quarter. Norges Bank bought a new stake in shares of Procter & Gamble during the fourth quarter worth $4,664,783,000. Finally, Price T Rowe Associates Inc. MD grew its holdings in shares of Procter & Gamble by 3.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 29,612,826 shares of the company’s stock worth $4,243,815,000 after purchasing an additional 1,091,091 shares during the last quarter. 65.77% of the stock is owned by institutional investors.

Insider Transactions at Procter & Gamble

In related news, CAO Matthew W. Janzaruk sold 359 shares of Procter & Gamble stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $145.24, for a total transaction of $52,141.16. Following the transaction, the chief accounting officer owned 1,271 shares of the company’s stock, valued at $184,600.04. This trade represents a 22.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Marc S. Pritchard sold 4,030 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $143.79, for a total transaction of $579,473.70. Following the transaction, the insider owned 187,001 shares of the company’s stock, valued at approximately $26,888,873.79. This represents a 2.11% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 6,627 shares of company stock worth $953,417. 0.20% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a report on Wednesday, June 24th. Barclays raised their price objective on shares of Procter & Gamble from $146.00 to $152.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 21st. Royal Bank Of Canada reiterated an “outperform” rating on shares of Procter & Gamble in a research report on Wednesday, August 19th. Citigroup decreased their price target on shares of Procter & Gamble from $181.00 to $170.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. Finally, HSBC reissued a “hold” rating and issued a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. Thirteen research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $161.19.

Get Our Latest Analysis on PG

Procter & Gamble Stock Performance

PG stock opened at $143.71 on Friday. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43. The company has a market cap of $334.04 billion, a P/E ratio of 21.71, a price-to-earnings-growth ratio of 4.41 and a beta of 0.39. The business’s fifty day moving average is $147.11 and its 200-day moving average is $148.28.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. The business had revenue of $21.20 billion during the quarter, compared to analysts’ expectations of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.The firm’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.48 earnings per share. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.98 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, August 17th. Stockholders of record on Friday, July 24th were given a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a dividend yield of 3.0%. The ex-dividend date was Friday, July 24th. Procter & Gamble’s payout ratio is presently 65.71%.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.